CJC-1295 with DAC is a synthetic GHRH analogue conjugated with a drug affinity complex that enables covalent albumin binding. In research settings, it is investigated for its extended interactions with GHRH receptor pathways, making it a subject of interest in studies on sustained somatotropic axis modulation and pharmacokinetic half-life extension models.